Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is 13.38 as of Friday, July 31, 2026.
Forward PE Ratio (13.38) = Close Price ($402.59) / Consensus Forward EPS ($29.57)
FORWARD PE RATIO
13.38
SECTOR MEDIAN · HEALTHCARE
19.05
median of 68 covered companies
CURRENT VS SECTOR MEDIAN
-29.78%
vs the sector median at left
HCA Healthcare, Inc.
Market Cap
$87.16B
Forward PE Ratio
13.38
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| HCA Healthcare, Inc. (HCA) | $87.16B | 13.38 |
| Elevance Health Inc. (ELV)vs › | $81.51B | 13.85 |
| Regeneron Pharmaceuticals, Inc. (REGN)vs › | $78.57B | 14.62 |
| McKesson Corporation (MCK)vs › | $100.24B | 21.95 |
| Cigna Corporation (CI)vs › | $73.82B | 9.45 |
| GSK plc (GSK)vs › | $103.56B | 14.59 |
| Boston Scientific Corporation (BSX)vs › | $69.46B | 14.11 |
| Medtronic plc (MDT)vs › | $109.30B | 15.53 |
| Cencora, Inc. (COR)vs › | $60.57B | 17.51 |
| Becton, Dickinson and Company (BDX)vs › | $60.00B | 13.13 |
Trailing P/E
13.6
reported TTM EPS
Forward P/E
13.4
consensus next-FY EPS
The gap between the two multiples is the consensus growth expectation: analysts' forward EPS of $29.57 implies +1.7% EPS growth vs the reported trailing $29.08.
At today's $402.59 close, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2026-12-31 | $29.57 | $28.91 – $30.22 | 14 | 13.6x |
| 2027-12-31 | $32.25 | $30.84 – $33.70 | 15 | 12.5x |
| 2028-12-31 | $35.46 | $32.89 – $38.45 | 11 | 11.4x |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
